Health Highlights: Dec. 2, 201012/02/10
Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
This Year Among Warmest on Record: U.N.
It's "almost certain" that 2010 will be one of the three warmest
years worldwide on record, and the past decade was the warmest
10-year period since the first weather records were recorded in
1850, says the World Meteorological Organization.
The United National agency data released at the U.N. climate
negotiations in Mexico confirmed that a global warming trend has
been occurring for decades, the
Associated Press reported.
The two other warmest years were 1998 and 2005. The average
temperatures of all three of the warmest years were within 0.02
degrees Celsius (0.036 Fahrenheit) of each other, WMO
Secretary-General Michel Jarraud told reporters.
He also said that natural temperature variation cannot explain
the record warmth that occurred between 2001 and 2010, the
Without taking man-made air pollution into account "you cannot
reproduce what you observe," in rising global temperatures, Jarraud
Retirees May Need More Than $100,000 for Health Expenses:
Even with Medicare coverage, a 65-year-old American who retires
this year may need more than $100,000 to cover premiums,
co-payments and other non-reimbursed medical costs during
retirement, according to a new report from the Employee Benefit
The institute said those retirement health costs are likely to
be higher for women because they live longer than men,
A 65-year-old man who retires in 2010, has average health
expenses, and is comfortable with a 50 percent chance of having
enough money saved for health expenses would need $65,000 in
savings. A woman in the same circumstances would need $93,000,
according to the institute.
But men who want to have a 90 percent chance of having enough
money saved for health expenses should have $124,000 and women
should have $152,000,
Emergency Contraceptive Pill Ella Now Available in U.S.
American women can now buy the controversial emergency
contraception pill "ella," drug maker Watson Pharmaceuticals Inc.
Women will need a doctor's prescription to get the pill, which
can prevent a pregnancy as many as five days after sex. The
wholesale price will be $35.75, the
Washington Post reported.
Ella, which was approved by the U.S. Food and Drug Adminstration
in August, was approved for sale in Europe last year and was
already available in at least 22 countries.
Proponents say the availability of ella in the United States
will provide an important new option to prevent unwanted
pregnancies. But critics say approving ella as a contraceptive is
misleading because it could be used to induce an abortion, the
Lap-Band Works for Patients Who Aren't Severely Obese: FDA
The Lap-Band weight-loss device is safe and effective in
patients who aren't as obese as current users, according to a
report released this week by U.S. Food and Drug Administration
Currenty, Lap-Band is approved for severely obese patients but
Allergan Inc. is seeking FDA approval to sell the device to people
who are less obese,
Bloomberg news reported.
The surgically-implanted device is an adjustable band that
reduces the amount of food that can be held by the stomach. The FDA
reviewers said clinical trials showed the Lap-Ban helped
non-severely obese patients lose weight and improved their quality
They also noted that there were no deaths and "only" 2.3 percent
of side effects were severe,
An FDA panel of outside advisers will meet Friday to decide
whether to recommend FDA approval of expanded use of the
Mylanta and Alternagel Antacids Recalled
A dozen types of Mylanta and one type of Alternagel antacid are
being recalled because they don't list the alcohol content of
flavoring agents, says Johnson & Johnson.
The company said there are no safety concerns related to the
recall of as many as 12 million bottles of Mylanta and 85,000
bottles of Alternagel and consumers can still use the products as
ABC News reported.
"Certain flavoring agents contribute small (less than 1 percent) amounts of alcohol," Johnson & Johnson said on the Mylanta website. "It is unlikely that use of these products will cause either absorption or alcohol sensitivity related adverse events."
So far this year, Johnson & Johnson has announced more than
half a dozen recalls that included products such as Children's
Tylenol, Benadryl, and Motrin,
ABC News reported.
Copyright © 2010
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.